Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions-Reference-Cited by-同舟云学术

Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions

Published:2018-10 Issue:5 Volume:79 Page:591-595
ISSN:0003-4266
Container-title:Annales d'Endocrinologie
language:en
Short-container-title:Annales d'Endocrinologie

Author:

Castinetti Frédéric,Albarel Frédéric,Archambeaud Françoise,Bertherat Jérome,Bouillet Benjamin,Buffier Perrine,Briet Claire,Cariou Bertrand,Caron Philippe,Chabre Olivier,Chanson Philippe,Cortet Christine,Do Cao Christine,Drui Delphine,Haissaguerre Magali,Hescot Ségolène,Illouz Frédéric,Kuhn Emmanuelle,Lahlou Najiba,Merlen Emilie,Raverot Véronique,Smati Sarra,Verges Bruno,Borson-Chazot Françoise

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference3 articles.

1. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Haanen;Ann Oncol,2017

2. Endocrine side effects induced by immune checkpoint inhibitors;Corsello;J Clin Endocrinol Metab,2013

3. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper;Champiat;Ann Oncol,2016

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitor (Pembrolizumab)- and Tyrosine Kinase Inhibitor (Axitinib)-induced Hypothyroidism, Hypogonadism, Adrenal Insufficiency, and Dysglycemia in a Patient with Renal Cell Carcinoma;Bangladesh Journal of Endocrinology and Metabolism;2024-09-12

2. Endocrine health in survivors of adult-onset cancer;The Lancet Diabetes & Endocrinology;2024-05

3. Clinically Approved Monoclonal Antibodies–based Immunotherapy: Association With Glycemic Control and Impact Role of Clinical Pharmacist for Cancer Patient Care;Clinical Therapeutics;2024-01

4. Progress and Challenges of Immune Checkpoint Inhibitor-Induced Hypophysitis;Journal of Clinical Medicine;2023-05-15

5. Pituitary and adrenal disorders induced by immune checkpoint inhibitors;Annales d'Endocrinologie;2023-05